IDO1 is a tryptophan metabolizing enzyme and mediates the tryptophan depletion to escape cytotoxic T cell killing, as a core element in tumor-promoting inflammation [63], the IDO inhibitor therapy have confirmed that IDO1 reduces the role of tumor immune response [64]. Here, IDO1 is linked to neoplasm.